Corneal Crosslinking Drug Gets Cautious Nod From FDA PanelCorneal Crosslinking Drug Gets Cautious Nod From FDA Panel

Experts wanted better data, but in the end decided that the UVA-irradiated drug would help patients with keratoconus and Lasik-surgery complications. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news